Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

317
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
317
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study).

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Task-oriented virtual reality and brain functional plasticity in progressive multiple sclerosis: A randomized controlled trial on upper limb rehabilitation.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Web-based family-reported outcomes to assess family functioning in multiple sclerosis: an Italian multicenter digital survey.

International journal of medical informatics·2026
Same author

Video-based 2D markerless gait analysis in people with multiple sclerosis.

Multiple sclerosis and related disorders·2026
Same author

Vocational rehabilitation for people with multiple sclerosis: A systematic scoping review of international evidence.

PloS one·2026
Same author

Increased functional network connectivity following cognitive rehabilitation in progressive multiple sclerosis with moderate to severe disabilty: findings from the CogEx study.

Journal of neurology·2026

相关实验视频

Updated: Jun 17, 2025

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

9.8K

血造干细胞移植用于多发性硬化症.

Giacomo Boffa1, Matilde Inglese2, Giovanni Luigi Mancardi1

  • 1Department of Neurology, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy.

Handbook of clinical neurology
|August 7, 2024
PubMed
概括

造血干细胞移植 (HSCT) 为其他疗法失败时的侵袭性多发性硬化症 (MS) 提供了一个有前途的治疗方法. 这种方法涉及强烈的免疫抑制和干细胞输液,全球有1800多名患者接受治疗.

关键词:
提高残疾改善的方法身体残疾的进展.磁力共振成像活动MRI活动多发性硬化症是多发性硬化症.复发复发的情况

更多相关视频

Surgical Transplantation of Mouse Neural Stem Cells into the Spinal Cords of Mice Infected with Neurotropic Mouse Hepatitis Virus
08:33

Surgical Transplantation of Mouse Neural Stem Cells into the Spinal Cords of Mice Infected with Neurotropic Mouse Hepatitis Virus

Published on: July 10, 2011

23.3K
Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
03:40

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Published on: December 8, 2023

956

相关实验视频

Last Updated: Jun 17, 2025

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

9.8K
Surgical Transplantation of Mouse Neural Stem Cells into the Spinal Cords of Mice Infected with Neurotropic Mouse Hepatitis Virus
08:33

Surgical Transplantation of Mouse Neural Stem Cells into the Spinal Cords of Mice Infected with Neurotropic Mouse Hepatitis Virus

Published on: July 10, 2011

23.3K
Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
03:40

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Published on: December 8, 2023

956

科学领域:

  • 神经学 神经学
  • 免疫学 免疫学 免疫学
  • 再生医学是一种再生医学.

背景情况:

  • 多发性硬化症 (MS) 的治疗方法已经进步,但长期缓解,特别是在侵袭性病例中,仍然很困难.
  • 造血干细胞移植 (HSCT) 正在成为攻击性MS的可行策略.
  • 在全球范围内,超过1800名多发性硬化患者接受了HSCT.

研究的目的:

  • 为积极的MS提供HSCT的概述.
  • 为突出MS患者接受HSCT的独特考虑.
  • 讨论HSCT对MS生物标志物的疗效,安全性和影响.

主要方法:

  • 对MS患者特定的HSCT程序的审查.
  • 对MS中HSCT有效性和安全性的现有证据的分析.
  • 关于HSCT对CSF,MRI和血清生物标志物的影响的初步数据的介绍.

主要成果:

  • 对于侵袭性多发性硬化症,HSCT的研究越来越多,全球有大量患者接受治疗.
  • 对于多发性硬化患者的具体考虑包括生育能力的保护,治疗失效和移植后监测.
  • 预先的数据表明,HSCT会影响中枢神经液,MRI指标和神经退行/脱线的生物标志物.

结论:

  • 对于激进的MS来说,HSCT代表了一个重要的治疗选择.
  • 根据国际指导方针进行仔细的患者选择至关重要.
  • 对HSCT的长期影响和生物标志物变化的进一步研究是有必要的.